These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 3296861

  • 1. Rheological and anticoagulant therapy of patients with chronic peripheral occlusive arterial disease (COAD).
    Deutschinoff A, Grozdinsky L.
    Angiology; 1987 May; 38(5):351-8. PubMed ID: 3296861
    [Abstract] [Full Text] [Related]

  • 2. Effects of buflomedil in a group of patients with chronic peripheral arterial diseases. Clinical and hemorheological evaluation.
    Mozzi E, Chiurazzi D, Spinola A, Annoni F, Germiniani R.
    J Int Med Res; 1985 May; 13(6):317-21. PubMed ID: 4076530
    [Abstract] [Full Text] [Related]

  • 3. Blood flow properties and walking performance in chronic arterial occlusive disease.
    Angelkort B, Spürk P, Habbaba A, Mähder M.
    Angiology; 1985 May; 36(5):285-92. PubMed ID: 3896044
    [Abstract] [Full Text] [Related]

  • 4. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
    Maksimović ZV.
    Srp Arh Celok Lek; 1999 May; 127(7-8):249-53. PubMed ID: 10624398
    [Abstract] [Full Text] [Related]

  • 5. [Effect of correction of rheological indicators of the blood on the results of treatment of patients with occlusive arterial diseases of the extremities].
    Mishchuk II, Shevchuk VR.
    Klin Khir (1962); 1987 May; (7):61-2. PubMed ID: 3656974
    [No Abstract] [Full Text] [Related]

  • 6. Intravenous treatment of chronic peripheral occlusive arterial disease: a double-blind, placebo-controlled, randomized, multicenter trial of pentoxifylline.
    Rudofsky G, Haussler KF, Künkel HP, Schneider-May H, Spengel F, Symann O, Werner HJ.
    Angiology; 1989 Jul; 40(7):639-49. PubMed ID: 2662830
    [Abstract] [Full Text] [Related]

  • 7. [Double-blind randomized controlled trial of ifenprodil tartrate versus placebo in chronic arterial occlusive disease of the legs at stage II of the Leriche and Fontaine classification].
    Branchereau A, Rouffy J.
    J Mal Vasc; 1995 Jul; 20(1):21-7. PubMed ID: 7745355
    [Abstract] [Full Text] [Related]

  • 8. Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
    Chopra HK, Chopra KL, Aggarwal KK, Parashar SK.
    J Med; 1988 Jul; 19(2):89-107. PubMed ID: 3049876
    [Abstract] [Full Text] [Related]

  • 9. Effects of defibrotide on physical performance and hemorheologic picture in patients with peripheral arteriopathy.
    Marrapodi E, Leanza D, Giordano S, Nazzari M, Corsi C.
    Clin Trials Metaanal; 1994 Apr; 29(1):21-30. PubMed ID: 10150182
    [Abstract] [Full Text] [Related]

  • 10. [Evaluation of the efficacy of medical treatment, especially anticoagulant treatment, in arteriopathies of the lower limbs. Apropos of 41 cases].
    Chérif T, Kallel N, Guediche M.
    Tunis Med; 1986 May; 64(5):475-80. PubMed ID: 3824555
    [No Abstract] [Full Text] [Related]

  • 11. Hypervolumetric hemodilution with HES 100/0.5 10% in patients with peripheral arterial occlusive disease (Fontaine, stage II): an open clinical and pharmacological phase IV study.
    Koscielny J, Latza R, Pruss A, Kiesewetter H, Jung F, Meier C, Schimetta W.
    Clin Hemorheol Microcirc; 2000 May; 22(1):53-65. PubMed ID: 10711822
    [Abstract] [Full Text] [Related]

  • 12. Pentoxifylline treatment in patients with occlusive peripheral arterial disease. Circulatory changes and effects on prostaglandin synthesis.
    Poggesi L, Scarti L, Boddi M, Masotti G, Serneri GG.
    Angiology; 1985 Sep; 36(9):628-37. PubMed ID: 3901827
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Antithrombotic drugs in peripheral arterial diseases].
    Verhaeghe R.
    J Mal Vasc; 1983 Sep; 8(1):23-7. PubMed ID: 6221056
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Hyper- or isovolemic hemodilution in patients with stage II peripheral arterial occlusive disease].
    Kiesewetter H, Jung F, Blume J, Spitzer S, Birk A.
    Acta Med Austriaca; 1991 Sep; 18 Suppl 1():23-7. PubMed ID: 1719729
    [Abstract] [Full Text] [Related]

  • 19. [Intravenous pentoxifylline in Fontaine stage II and III peripheral arterial diseases].
    Giansante C, Di Chiara A, Fiotti N, Mauri F, Sorrentino A, Spanghero M, Tomasin L, Calabrese S.
    Clin Ter; 1990 Sep 15; 134(5):301-5. PubMed ID: 2149312
    [Abstract] [Full Text] [Related]

  • 20. [Therapeutic use of flunarizine in the treatment arteriopathies of the lower extremities].
    Ambrosi V, Gabrielli F.
    Minerva Med; 1983 Mar 31; 74(13):685-9. PubMed ID: 6220230
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.